کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8769986 | 1598217 | 2018 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
Synthetic cannabinoids - Canabinoids مصنوعیRecreational drug use - استفاده از مواد مخدر تجارتیChronic kidney disease (CKD) - بیماری مزمن کلیه (CKD)end-stage renal disease (ESRD) - بیماری کلیوی مرحله پایانی (ESRD)Anorexia - بیاشتهاییNausea - تهوعpruritus - خارشchronic pain - درد مزمنCannabis - شاهدانهMedical marijuana - ماری جوانا پزشکیMarijuana - ماریجوآناTransplantation - پیوندCachexia - کاچکسی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
بیماریهای کلیوی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Marijuana is the most commonly used recreational drug in the United States, and legal recreational and medicinal use has gained public acceptance during the last decade. Twenty-nine US states have established medical marijuana programs, 8 of which have also legalized recreational marijuana, and Canada is expected to legalize recreational marijuana in 2018. Advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD) are chronic conditions with significant associated morbidity and mortality. Patients experience substantial symptom burden that is frequently undertreated due to adverse medication side effects. This article reviews the available evidence for the use of medical marijuana to manage chronic pain, nausea/vomiting, anorexia/cachexia, and pruritus, all of which are frequently reported by patients with advanced CKD or ESRD. Potential adverse health effects of medical and recreational marijuana use are also discussed. Regardless of personal, social, and political beliefs, marijuana use is becoming mainstream, and nephrologists should be aware of the potential impact on our patient population. Further research is warranted to investigate the renal endocannabinoid system, the impact of marijuana use on kidney disease outcomes, and the risks and benefits of medical marijuana use on symptoms of advanced CKD and ESRD.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: American Journal of Kidney Diseases - Volume 71, Issue 2, February 2018, Pages 267-274
Journal: American Journal of Kidney Diseases - Volume 71, Issue 2, February 2018, Pages 267-274
نویسندگان
Joshua L. Rein, Christina M. Wyatt,